Suppr超能文献

人类肠道微生物群在健康与保健中的相互作用。

Interplay of Human Gut Microbiome in Health and Wellness.

作者信息

Singhvi Nirjara, Gupta Vipin, Gaur Mohita, Sharma Vishal, Puri Akshita, Singh Yogendra, Dubey Gyanendra P, Lal Rup

机构信息

1Department of Zoology, University of Delhi, Delhi, 110007 India.

2Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France.

出版信息

Indian J Microbiol. 2020 Mar;60(1):26-36. doi: 10.1007/s12088-019-00825-x. Epub 2019 Sep 5.

Abstract

The gut microbiome analysis, with specific interest on their direct impact towards the human health, is currently revolutionizing the unexplored frontiers of the pathogenesis and wellness. Although in-depth investigations of gut microbiome, 'the Black Boxes', complexities and functionalities are yet at its infancy, profound evidences are being reported for their concurrent involvement in disease etiology and its treatment. Interestingly, studies from the 'minimal murine' (Oligo-MM), 'humanized' microbiota gnotobiotic mice models and patient samples, combined with multi-omics and cell biology approaches, have been revealing the implications of these findings in the treatment of gut dysbiosis associated diseases. Nonetheless, due to the inherent heterogeneity of the gut commensals and their unified co-existence with opportunistic pathobionts, it is utmost essential to highlight their functionalities in 'good or bad' gut in human wellness. We have specifically reviewed dietary lifestyle and infectious diseases linked with the gut bacterial consortia to delineate the ecobiotic approaches towards their treatment. This notably includes gut mucosal immunity mediated diseases such as Tuberculosis, IBD, CDI, Type 2 Diabetes, etc. Alongside of each dysbiosis, we have described the current therapeutic advancements of the pre- and probiotics derived from human microbiome studies to restore gut microbial homeostasis. With a continuous running debate on the role of microbiota in above mentioned diseases, we have collected numerous scientific evidences highlighting a previously unanticipated complex involvement of gut microbiome in the potential of human health.

摘要

对肠道微生物群的分析,特别是关注其对人类健康的直接影响,目前正在彻底改变发病机制和健康领域尚未探索的前沿。尽管对肠道微生物群这个“黑匣子”的深入研究、复杂性和功能仍处于起步阶段,但已有大量证据表明它们同时参与疾病病因及其治疗。有趣的是,来自“最小化小鼠”(寡聚-MM)、“人源化”微生物无菌小鼠模型和患者样本的研究,结合多组学和细胞生物学方法,一直在揭示这些发现对肠道菌群失调相关疾病治疗的意义。然而,由于肠道共生菌固有的异质性以及它们与机会性致病共生菌的共同存在,在人类健康中突出它们在“好或坏”肠道中的功能至关重要。我们特别回顾了与肠道细菌群落相关的饮食生活方式和传染病,以描述针对它们治疗的生态疗法。这尤其包括肠道黏膜免疫介导的疾病,如结核病、炎症性肠病、艰难梭菌感染、2型糖尿病等。除了每种菌群失调,我们还描述了源自人类微生物组研究的益生元和益生菌在恢复肠道微生物稳态方面的当前治疗进展。随着关于微生物群在上述疾病中作用的持续争论,我们收集了大量科学证据,突出了肠道微生物群在人类健康潜力中以前未预料到的复杂参与。

相似文献

1
Interplay of Human Gut Microbiome in Health and Wellness.
Indian J Microbiol. 2020 Mar;60(1):26-36. doi: 10.1007/s12088-019-00825-x. Epub 2019 Sep 5.
2
The Human Gut Microbiome - A Potential Controller of Wellness and Disease.
Front Microbiol. 2018 Aug 14;9:1835. doi: 10.3389/fmicb.2018.01835. eCollection 2018.
3
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
5
Psoriasis: Interplay between dysbiosis and host immune system.
Autoimmun Rev. 2022 Nov;21(11):103169. doi: 10.1016/j.autrev.2022.103169. Epub 2022 Aug 12.
6
Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Clin Exp Immunol. 2015 Mar;179(3):363-77. doi: 10.1111/cei.12474.
8
Restoration of dysbiotic human gut microbiome for homeostasis.
Life Sci. 2021 Aug 1;278:119622. doi: 10.1016/j.lfs.2021.119622. Epub 2021 May 17.
9
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul.
10
Influence of gut microbiota on eye diseases: an overview.
Ann Med. 2021 Dec;53(1):750-761. doi: 10.1080/07853890.2021.1925150.

引用本文的文献

1
Insights into the gut-liver axis: mechanisms and emerging therapies in hepatocellular carcinoma.
Front Pharmacol. 2025 May 19;16:1595853. doi: 10.3389/fphar.2025.1595853. eCollection 2025.
3
Role of Gut Microbiome in Cancer Treatment.
Indian J Microbiol. 2024 Sep;64(3):1310-1325. doi: 10.1007/s12088-024-01340-4. Epub 2024 Jun 27.
4
From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?).
Indian J Microbiol. 2024 Sep;64(3):810-820. doi: 10.1007/s12088-024-01267-w. Epub 2024 Apr 3.
5
Probiotic consumption and hepatic steatosis: results from the NHANES 2011-2016 and Mendelian randomization study.
Front Nutr. 2024 Apr 8;11:1334935. doi: 10.3389/fnut.2024.1334935. eCollection 2024.
6
Celiac Disease: A Review from Genetic to Treatment.
Iran Biomed J. 2024 Jan 1;28(1):8-14. doi: 10.61186/ibj.4028. Epub 2023 Dec 2.
8
Biosensors for point-of-care testing and personalized monitoring of gastrointestinal microbiota.
Front Microbiol. 2023 May 5;14:1114707. doi: 10.3389/fmicb.2023.1114707. eCollection 2023.
9
Effect of Non-Nutritive Sweeteners on the Gut Microbiota.
Nutrients. 2023 Apr 13;15(8):1869. doi: 10.3390/nu15081869.
10
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.
Front Endocrinol (Lausanne). 2023 Mar 23;14:1149256. doi: 10.3389/fendo.2023.1149256. eCollection 2023.

本文引用的文献

1
A Glimpse into the Microbiota of Marketed Ready-to-Eat Crickets ().
Indian J Microbiol. 2020 Mar;60(1):115-118. doi: 10.1007/s12088-019-00817-x. Epub 2019 Aug 3.
2
Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.
Indian J Microbiol. 2020 Mar;60(1):12-25. doi: 10.1007/s12088-019-00808-y. Epub 2019 May 25.
3
Chicken Gut Microbiome and Human Health: Past Scenarios, Current Perspectives, and Futuristic Applications.
Indian J Microbiol. 2020 Mar;60(1):2-11. doi: 10.1007/s12088-019-00785-2. Epub 2019 Feb 8.
4
Characterization of Skin Microbiome in Tinea Pedis.
Indian J Microbiol. 2019 Dec;59(4):422-427. doi: 10.1007/s12088-019-00816-y. Epub 2019 Jul 10.
5
Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism.
Cell Rep. 2019 Apr 16;27(3):750-761.e7. doi: 10.1016/j.celrep.2019.03.054.
6
The lung microbiome, vitamin D, and the tuberculous granuloma: A balance triangle.
Microb Pathog. 2019 Jun;131:158-163. doi: 10.1016/j.micpath.2019.03.041. Epub 2019 Apr 3.
7
Fight them or feed them: how the intestinal mucus layer manages the gut microbiota.
Gastroenterol Rep (Oxf). 2019 Feb;7(1):3-12. doi: 10.1093/gastro/goy052. Epub 2019 Feb 13.
8
Mining the Core Gut Microbiome from a Sample Indian Population.
Indian J Microbiol. 2019 Mar;59(1):90-95. doi: 10.1007/s12088-018-0742-0. Epub 2018 May 18.
10
Prevalence of Diabetes Mellitus and its Predictors among Tuberculosis Patients Currently on Treatment.
Indian J Community Med. 2018 Oct-Dec;43(4):302-306. doi: 10.4103/ijcm.IJCM_230_18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验